SCHEMBL26967936

SCHEMBL26967936

O=C1NCCC1OC1CCCC1

nearest known ligand 0.37

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CCR2 P41597 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26967932 0.91 L3MBTL1 (0.32) L3MBTL1KDM4EALDH1A1
SCHEMBL18231654 0.71
SCHEMBL12683411 0.71
SCHEMBL21246444 0.71
SCHEMBL7470576 0.71
SCHEMBL10086922 0.71
SCHEMBL12683410 0.71
SCHEMBL29346507 0.69 CRBN (0.39)
SCHEMBL21256339 0.68 NAAA (0.37)
SCHEMBL11084174 0.67 POLB (0.35) L3MBTL1ALDH1A1CCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240158348-A1 HERBICIDAL CYCLIC AMIDES N-SUBSTITUTED WITH A HALOALKYLSULFONYLANILIDE GROUP FMC CORPORATION 2024-05-16 US disclosed
EP-4294791-A1 HERBICIDAL CYCLIC AMIDES N-SUBSTITUTED WITH A HALOALKYLSULFONYLANILIDE GROUP FMC CORPORATION (US) 2023-12-27 EP disclosed
CN-116888097-A Haloalkyl sulfonamide anilino N-substituted herbicidal cyclic amides FMC公司 2023-10-13 CN disclosed
WO-2022177892-A1 HERBICIDAL CYCLIC AMIDES N-SUBSTITUTED WITH A HALOALKYLSULFONYLANILIDE GROUP FMC CORPORATION (US) 2022-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240158348-A1 HERBICIDAL CYCLIC AMIDES N-SUBSTITUTED WITH A HALOALKYLSULFONYLANILIDE GROUP CBR3, NQO2, CBR1 PDE4A 707/4885PDE4B 697/4885PDE4C 544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.